Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is administered as a weekly subcutaneous injection, meaning it goes into the fatty tissue just beneath your skin rather than into muscle or vein. Choosing the correct injection site and rotating between locations reduces irritation, bruising, and ensures consistent medication absorption. Understanding proper injection anatomy helps you get the most from your compounded semaglutide therapy.
Primary Semaglutide Injection Sites
The abdomen, thigh, and upper arm are the three main locations where semaglutide injections are safely administered. Each site contains a layer of subcutaneous fat that allows the medication to disperse properly over the week. Your healthcare provider may recommend starting with one preferred location based on your body composition and comfort level.
The abdomen offers the largest injection area and remains the most common choice among patients starting semaglutide therapy. Inject at least two finger-widths away from your belly button to avoid the deeper tissues beneath the abdominal wall. The outer thigh, either front or side surface, works well for patients who prefer injecting themselves or having a partner assist with the procedure.
How to Rotate Injection Sites Properly
Rotating your injection site each week prevents lipodystrophy, a condition where repeated injections in the same spot can cause fat loss or thickening of tissue. A simple rotation pattern uses different areas of your abdomen one week, a thigh the next week, and an upper arm the third week. Within each body area, move your injection point by at least one inch to a fresh location on the skin.
Keep a written log or use your phone's calendar to track which site you used each week so rotation becomes automatic. If you notice redness, warmth, or unusual swelling at a previous injection site, wait at least two weeks before using that exact location again. Proper rotation supports better medication absorption and reduces the injection-site reactions that can affect your weight loss results.
Injection Technique and Depth for Semaglutide
Subcutaneous injection depth typically ranges from one-quarter inch to one-half inch beneath the skin surface, roughly the thickness of a pencil eraser. Pinch the skin at your chosen site, clean the area with an alcohol swab, and insert the needle at a 45 to 90-degree angle depending on your body composition and comfort. Most patients find a perpendicular approach easier to control, though some prefer a slight angle to reduce nerve irritation.
After inserting the needle to the proper depth, inject the medication steadily without rushing; this prevents tissue damage and allows the medication to distribute evenly. Leave the needle in place for three to five seconds after injecting to ensure the full dose has entered the subcutaneous space. Remove the needle slowly and apply gentle pressure with a cotton ball if needed, though bleeding is typically minimal with this injection type.
Why PlexusDx Compounded Semaglutide Works at These Sites
PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which formulate the medication with the same active ingredient found in brand-name versions. The compounding process does not alter how semaglutide is absorbed when injected into subcutaneous tissue, meaning your chosen injection sites work identically whether you use a brand or compounded product. Starting at $149 per month, PlexusDx semaglutide reaches all 50 states without insurance requirements, making weekly injections accessible and affordable.
Your dose may need to go up as your body responds to treatment, but your monthly price remains flat—this pricing model reflects PlexusDx's commitment to transparent, predictable costs. Patients can also explore the Precision Peptide Genetic Test, a $99 add-on after your first month, which maps your response to semaglutide across 14 metabolic pathways and 49 peptides. Understanding your genetic predisposition to GLP-1 response helps your provider optimize both your injection protocol and dose timing.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide anywhere on my body?
No, semaglutide requires subcutaneous injection into areas with adequate fat tissue: the abdomen, thigh, or upper arm. Injecting into bone, muscle, or vein can cause serious complications. Always follow your healthcare provider's guidance on approved injection sites specific to your anatomy.
What happens if I inject semaglutide into the same spot twice?
Repeated injections in the same location can lead to lipodystrophy, causing either fat loss (lipoatrophy) or fat buildup (lipohypertrophy) that interferes with medication absorption. Rotating sites weekly prevents this complication and ensures consistent drug delivery for steady weight loss results.
Does PlexusDx semaglutide work differently than brand Ozempic when injected?
No, PlexusDx compounded semaglutide contains the same active pharmaceutical ingredient and absorbs identically when injected into subcutaneous tissue. The medication is formulated by licensed 503A compounding pharmacies and works the same way at any approved injection site, costing from $149 per month with no flat per-compound pricing increases.
What should I do if my injection site becomes red or swollen?
Minor redness or warmth at the injection site usually resolves within hours and is not dangerous. However, if redness, swelling, or pain persists beyond 48 hours or worsens, contact your healthcare provider immediately. Do not inject at that location again until it has fully healed, and consider alternating sites more frequently.
Can my genetic test tell me which injection site works best?
The PlexusDx Precision Peptide Genetic Test examines your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways to predict how well you'll respond to semaglutide, not which injection site is optimal. All approved injection sites work equally well genetically; the test helps your provider personalize your dose and frequency for maximum effectiveness.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Wegovy Works Compared to Mounjaro for Sustainable Weight Loss
Reasons You Haven’t Lost Weight on Ozempic: Understanding the Challenges